ComplianceOnline
Join for Free
Signin
Welcome back! Please log in below to continue.
Forgot Password?
New customer? Free Signup
Your Shopping Cart
Contains 0items
Total: $0.00
View Shopping Cart
Home › Best Practices ›  Packaging and Labeling

Changes in Labeling Statin Drugs – What the New FDA Draft Guidance Says

  • By: Staff Editor
  • Date: April 16, 2012
Webinar All Access Pass Subscription Abstract:

On Feb 28 2012, the FDA released new draft guidance on safety changes for widely used cholesterol – lowering or statin drugs. These regulations aim to educate, update health care professionals and patients about the health benefits as well as risks associated with these drugs.

Click here for detail description
Bookmark and Share

Compliance Trainings

PET Container Stress Cracking - Mythology and Science
By - Stephen Zagarola
On Demand Access Anytime
Reprocessing Reusable Medical Devices - Cleaning and Labeling Requirements
By - John Chapman
On Demand Access Anytime
Packaging Validation & Shipping Qualification
By - Richard Gaeto
On Demand Access Anytime
Regulatory requirements on pharmaceutical packaging materials from US and EU points of view
By - Paul Chen
On Demand Access Anytime
View all Trainings

Compliance Standards

More Standards »
Best Sellers
PrevNext
You Recently Viewed
  • No Records Found
  • No Records Found
  • No Records Found
PrevNext
Copyright © 2025 ComplianceOnline.com
MetricStream
Our Policies: Terms of use | Privacy